黑色素受体激活剂与心律失常之间的关联;使用药监数据库进行不成比例分析研究
Rikuto Masuda1, Yoshihiro Noguchi2, Tomoaki Yoshimura3
1Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, 1-25-4 Daigakunishi, Gifu-Shi, Gifu, 501-1196, Japan.
Cardiovascular toxicology
|June 23, 2025
概括
与二二胺受体激动剂相比,二胺受体激动剂与心律失常的关联较弱. 这表明黑激素激动剂在失眠药物安全性方面的潜在心脏保护作用.
科学领域:
- 药监和心血管安全 药监和心血管安全
- 药物诱导的心律失常症
- 监管科学 监管科学
背景情况:
- 失眠药物,如二二胺受体激动剂 (BZRAs),与心律失常有关.
- 黑色素受体激活剂 (MRAs) 可能提供心脏保护性益处.
研究的目的:
- 调查MRA使用与心律失常之间的关联.
- 为了比较MRA和BZRA的心脏安全概况.
主要方法:
- 使用了食品和药物管理局的不良事件报告系统 (FAERS) 数据库.
- 使用标准化MedDRA查询 (SMQ) 分析了心律不整的数据.
- 计算了报告几率比率 (ROR) 来评估药物事件的关联.
主要成果:
- MRAs与所有心律失常SMQ (例如",心律失常"ROR:0.47) 显示出负相关性.
- BZRAs与心律失常相关的SMQs显示出正相关性.
- 针对MRA的特定ROR表明不同类型的心律失常症的风险降低.
结论:
- 与BZRA不同,MRA的使用与心律失常有很弱的关联.
- 对于心脏事件的失眠治疗,MRA可能是一个更安全的替代方案.
相关概念视频
Pharmacovigilance
1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
248
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
248
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
908
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
908
Management of Insomnia
328
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
328
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
137
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
137
Mechanism of Cardiac Arrhythmias
1.1K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.1K


